Aptimmune Biologics specializes in developing revolutionary mucosal vaccines that provide unsurpassed efficacy against the viral diseases most costly to the swine industry. 

Biotechnology

Aptimmune Biologics

Heather Bessoff

Federico A. Zuckermann

Gabriela Calzada

The executive team at Aptimmune Biologics has experience in the animal science and veterinary industries, as well as experience with commercialization and business development. The team members have degrees from the University of Connecticut and Pfizer, and have worked for companies such as EpiBiome, Elanco, and Dairy Management Solutions.

CEO and Executive Team

About

Team members

Other teams at Aptimmune Biologics

Board of Directors

Leadership Team